First Patient Enrolled in Merakris-Sponsored VA Clinical Trial
![Merakis Logo](https://nationalstemcelltherapy.com/wp-content/uploads/2022/06/merakris-logo.jpg)
RESEARCH TRIANGLE PARK, N.C., July 27, 2022 (GLOBE NEWSWIRE) — The first patient has been enrolled in a Phase II clinical trial – sponsored by Merakris Therapeutics – to measure the safety and efficacy of its investigational wound care product, Dermacyte® Amniotic Wound Care Liquid, for the treatment of non-healing venous stasis ulcers. The Research […]